Kiyoshima C, Kimura I, Ishida K, Hirano T, Ishida T, Shigekawa K
Cureus. 2025; 17(1):e77114.
PMID: 39925535
PMC: 11802933.
DOI: 10.7759/cureus.77114.
Vega C, Medina N, Quintana-Quintana L, Leon R, Fabelo H, Rial J
Sci Rep. 2025; 15(1):820.
PMID: 39755771
PMC: 11700083.
DOI: 10.1038/s41598-024-84422-z.
Liu Q, Yang J, Cheng H, Shu C, Tang Y, Zhao J
Cancer Med. 2024; 14(1):e70540.
PMID: 39739926
PMC: 11683552.
DOI: 10.1002/cam4.70540.
Knudsen A, Randrup T, Kesmodel U, Booth B, Gustafson L, Trope A
BMJ Open. 2024; 14(12):e085382.
PMID: 39675832
PMC: 11647325.
DOI: 10.1136/bmjopen-2024-085382.
Kim J, Shim J
J Pathol Transl Med. 2024; 58(6):283-290.
PMID: 39557409
PMC: 11573476.
DOI: 10.4132/jptm.2024.10.17.
Effect of Clinicopathological Characteristics on the Outcomes of Topical 5-Aminolevulinic Acid Photodynamic Therapy in Patients with Cervical High-Grade Squamous Intraepithelial Lesions (HSIL/CIN2): A Retrospective Cohort Study.
Wei Y, Niu J, Gu L, Hong Z, Bao Z, Qiu L
Biomedicines. 2024; 12(10).
PMID: 39457568
PMC: 11504644.
DOI: 10.3390/biomedicines12102255.
Surgical, oncological and obstetric outcomes of the Shimodaira-Taniguchi conization method.
Higami S, Tanaka Y, Deguchi T, Shiraishi M, Shiki Y
Mol Clin Oncol. 2024; 21(5):84.
PMID: 39301123
PMC: 11411606.
DOI: 10.3892/mco.2024.2782.
HPV vaccination strategy for 14-year-old females and economic returns for cervical cancer prevention in Wuxi City, China: a cost effectiveness analysis.
Jiang J, Zhao F, Hong X, Wang X
Cost Eff Resour Alloc. 2024; 22(1):64.
PMID: 39237947
PMC: 11378447.
DOI: 10.1186/s12962-024-00574-9.
To cut or not to cut - that is the question: a comparative analysis of long-term follow-up after complete and incomplete electroconization of the cervix due to high-grade squamous intraepithelial lesion.
Suchonska B, Gajewska M, Blok J
Front Oncol. 2024; 14:1421738.
PMID: 39211556
PMC: 11357963.
DOI: 10.3389/fonc.2024.1421738.
Cervical Intraepithelial Neoplasia Grade 3 (CIN3) in Women Younger than 30 Years Was Significantly Associated with HPV16/18 Genotypes.
Bruno M, Panella M, Valenti G, Ruggeri Z, Sgalambro F, Reina S
Cancers (Basel). 2024; 16(11).
PMID: 38893161
PMC: 11171186.
DOI: 10.3390/cancers16112043.
PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16/18-positive women undergoing colposcopy.
Lu Y, Wu H, Fu K, Shen Y, Li L, Liao Z
Clin Epigenetics. 2024; 16(1):77.
PMID: 38849868
PMC: 11157736.
DOI: 10.1186/s13148-024-01691-1.
Development of a machine learning-based model for predicting positive margins in high-grade squamous intraepithelial lesion (HSIL) treatment by Cold Knife Conization(CKC): a single-center retrospective study.
Zhang L, Zheng Y, Lei L, Zhang X, Yang J, Zeng Y
BMC Womens Health. 2024; 24(1):332.
PMID: 38849836
PMC: 11157760.
DOI: 10.1186/s12905-024-03180-2.
Rapid, high-resolution, non-destructive assessments of metabolic and morphological homogeneity uniquely identify high-grade cervical precancerous lesions.
Polleys C, Singh P, Thieu H, Genega E, Jahanseir N, Zuckerman A
bioRxiv. 2024; .
PMID: 38798665
PMC: 11118292.
DOI: 10.1101/2024.05.10.593564.
Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.
Rebolj M, Brentnall A, Cuschieri K
Br J Cancer. 2024; 130(11):1733-1743.
PMID: 38615108
PMC: 11130303.
DOI: 10.1038/s41416-024-02681-z.
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts.
Diakite I, Martins B, Owusu-Edusei K, Palmer C, Patterson-Lomba O, Gomez-Lievano A
Infect Dis Ther. 2024; 13(5):965-990.
PMID: 38589763
PMC: 11098984.
DOI: 10.1007/s40121-024-00952-z.
Human Oncogenic Viruses: Characteristics and Prevention Strategies-Lessons Learned from Human Papillomaviruses.
Galati L, Chiantore M, Marinaro M, Di Bonito P
Viruses. 2024; 16(3).
PMID: 38543781
PMC: 10974567.
DOI: 10.3390/v16030416.
Effects of 5-aminolevulinic acid photodynamic therapy for cervical low-grade squamous intraepithelial lesions with HR-HPV infections.
Li Y, Chen J, Hu Y, Xu Q, Jiang R, Teng Y
Front Med (Lausanne). 2024; 10:1301440.
PMID: 38404461
PMC: 10885802.
DOI: 10.3389/fmed.2023.1301440.
Human papillomavirus and cervical cancer in the microbial world: exploring the vaginal microecology.
Zhang Z, Ma Q, Zhang L, Ma L, Wang D, Yang Y
Front Cell Infect Microbiol. 2024; 14:1325500.
PMID: 38333037
PMC: 10850380.
DOI: 10.3389/fcimb.2024.1325500.
A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2.
Cho H, Jeong S, Song S, Kim Y, Kim J, Cho C
J Gynecol Oncol. 2024; 35(4):e52.
PMID: 38330377
PMC: 11262905.
DOI: 10.3802/jgo.2024.35.e52.
Stochastic dynamics of human papillomavirus delineates cervical cancer progression.
Phan T, Sarower F, Duan J, Tian J
J Math Biol. 2023; 87(6):85.
PMID: 37951849
PMC: 11085997.
DOI: 10.1007/s00285-023-02018-z.